Peer-reviewedCC BY-NCNeuropsychiatric disease and treatment
Irreversible Primary Visual Cortex Impairment in a Mouse Model of High-Risk Schizophrenia [Retraction].
Abstract
[This retracts the article DOI: 10.2147/NDT.S246163.].
Related
- Glutathione-related redox imbalance and cognitive impairment in drug-naïve, first-episode schizophrenia: a focus on GSSG
- Effects of mindfulness-based yoga and physical exercise on psychological well-being in individuals with visual impairment: a three-armed randomized controlled trial
- Components of service delivery for the detection, care and management of children with cerebral visual impairment: a scoping review.
- Extracellular vesicle miRNAs, NOS/NO homeostasis, and NLRP3 inflammasome signaling in schizophrenia-related cognitive impairment: a mechanistic review and testable hypothesis
- Content Validity and Psychometric Properties Assessment of the Virtual Reality Functional Capacity Assessment Tool and Application in Multiregional Clinical Trials of Cognitive Impairment Associated with Schizophrenia.
BibTeX
@article{anon2026irreversible,
title = {{Irreversible Primary Visual Cortex Impairment in a Mouse Model of High-Risk Schizophrenia [Retraction].}},
journal = {Neuropsychiatric disease and treatment},
year = {2026},
month = oct,
doi = {10.2147/ndt.s665120},
url = {https://europepmc.org/article/MED/42948448},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Irreversible Primary Visual Cortex Impairment in a Mouse Model of High-Risk Schizophrenia [Retraction].
PY - 2026
DA - 2026/10/23
JO - Neuropsychiatric disease and treatment
DO - 10.2147/ndt.s665120
UR - https://europepmc.org/article/MED/42948448
AB - [This retracts the article DOI: 10.2147/NDT.S246163.].
SN - 1176-6328
SN - 1178-2021
ER -